Emerging Health Innovators Teaming Profiles
Thank you for showing an interest in ARPA-H’s Emerging Health Innovators (EHI) initiative. This page is designed to help facilitate connections between prospective proposers. If either you or your organization are interested in teaming, please submit your information via the portal linked below. Your details will then be added to the list below, which is publicly available.
EHI anticipates that teaming will be necessary to achieve the goals of the initiative. Prospective performers are encouraged (but not required) to form teams with varied technical expertise to submit a proposal to the EHI solicitation.
Please note that by publishing the teaming profiles list, ARPA-H is not endorsing, sponsoring, or otherwise evaluating the qualifications of the individuals or organizations included here. Submissions to the teaming profiles list are reviewed and updated periodically.
Interested in learning more about the EHI initiative?
- Read the EHI Special Notice.
- Register to attend the virtual Proposers’ Day on January 8.
- View the EHI initiative overview page.
EHI Teaming Cards
To narrow the results in the Teaming Profiles List, please use the input below to filter results based on your search term. The list will filter as you type.
| Contact | Organization Name | Location | Description of Research Focus Area | Description of Teaming Partner | Technical Areas | |
| Yixue Zhao | USC/ISI | yzhao@isi.edu | Arlington, VA | 1. USC Information Sciences Institute (AI/ML, Mobile Technology, Software Engineering, Mental Health, Digital Wellbeing) 2. Freedom of Mind (https://www.freedom-of-mind.org/): Education foundation focusing on Mindfulness/Meditation Education | Neuroscientists/Mental Health Professionals or Organizations interested in Mindfulness/Meditation | Track 2 - Community-Centered Innovation |
| Jacob Jones | Scottish Rite For Children | jacob.jones@tsrh.org | Dallas, TX | Using musculoskeletal ultrasound to diagnose, screen, and treat musculoskeletal issues in pediatric and adolescent populations | Technology partners, ultrasound imaging partners that can aid in expanding the use of ultrasound to diagnose, screen, and treat MSK issues in pediatric and adolescent populations. | Track 1 - Technology-Driven Innovation |
| Allen Olson-Urtecho | Studio Bahia | allen@studiobahia.org | San Antonio, TX | Studio Bahia was founded in response to children as young as 9 years old committing suicide and self-harm in refugee camps. This led to the development of Lili VR kits, which have expanded beyond camps into hospitals, supporting pain management, anxiety reduction, and distraction therapy. We are now tackling the U.S. mental health crisis by creating 10-minute VR interventions for people with depression, offering accessible, scalable, and impactful mental health support. | We seek to partner with community health organizations, academics with clinical experience, and institutions aiming to scale mental health programs. Our focus is on supporting populations living with depression and major depressive disorder through collaborative efforts and impactful, scalable solutions. www.studiobahia.org | Track 2 - Community-Centered Innovation |
| Demet Sag | Genome2Life | dgrace@genome2life.com | Boston, MA | Our team is deeply committed to shedding light on the mysteries surrounding these intriguing biomolecules and their potential implications in cancer pathogenesis. Early investigations have revealed compelling evidence of their involvement in tumor growth and progression at the pregnancy and disease cusp. | Looking for funding, computer biology, biosensor technology, biomedical, and clinical expertise. | Track 1 - Technology-Driven Innovation |
| Communications Team HealthReach | HealthReach Community Health Centers | pr@healthreach.org | Waterville (our service area is all of Central & Western Maine), ME | Improving means by which to reach out to community members with important public health and healthcare information. | A dedication to prioritizing community health needs, and operational capacity to meaningfully contribute to a joint effort | Track 2 - Community-Centered Innovation |
| Kuang Gong | University of Florida | kgong@ufl.edu | Gainesville, FL | AI-based disease diagnosis, treatment planning, and prognosis; Medical Imaging; Image Reconstruction; Medical Physics; Data Science; | AI algorithm development; Mechanisms of disease; Biomarker discovery; AI algorithm deployment; | Track 1 - Technology-Driven Innovation |
| Muhammad Adib Uz Zaman | University of Cincinnati | adib.zaman@uc.edu | Cincinnati, OH, OH | Health IT innovation using translational research involving EHR, claims, clinical notes, medical images | Health experts from College of medicine, pharmacy, nursing, psychology and related domains. | Track 1 - Technology-Driven Innovation |
| Sajjad Moazeni | University of Washington | smoazeni@uw.edu | Seattle, WA | Miniaturized and multi-functional sensing/imaging implantable and wearables for various screening and treatment monitoring applications | technologies for pediatric biomedical devices, cancer imaging, and diabetes | Track 1 - Technology-Driven Innovation |
| Daisy Gallagher | TheraSyn Bio, Inc. | dgallagher@therasynbio.com | USA based, MA | Synthetic Biology (SynBio) is an area of research, creating new biological devices, systems, and redesigning systems already in nature. It is an area of science that encompasses a broad range of methodologies from various disciplines, which includes bioscience research, biotech, molecular biology, molecular engineering, systems biology, membrane science, biophysics, and evolutionary biology. | Support and backgriund in our focus areas and funding | Track 1 - Technology-Driven Innovation |
| Aditya Kunjapur | University of Delaware | kunjapur@udel.edu | Newark, DE | My lab innovates in the areas of programming cells to create and harness new building blocks. We design biochemical pathways to allow cells to access protein chemistries autonomously, for purposes including immunomodulation. We also design systems that make the survival of microbes rely on the provision of a non-standard amino acid, leading to intrinsic biological containment. We also conduct research in broad adjacent areas of microbial synthetic biology and mammalian cell culture. | Clinical experience; Translation to the clinic; Computational expertise; Disease-specific expertise; Manufacturing and Formulation | Track 1 - Technology-Driven Innovation |
| Stefany Goradia | HealthTech Rx | Stefany@htrx.io | Albuquerque, NM | Population health innovation for underserved communities, through digital health technologies and community co-design | Technologists, community-based partners, digital health and implementation experts | Track 2 - Community-Centered Innovation |
| Sameer Peesapati | Synthesize | sameer@synthesize.health | San Francisco, CA | Use of AI in care delivery and population health initiatives. | We are looking to team up with community health partners to improve care delivery and care accessibility in healthcare deserts. We are also seeking partners who work with populations living with chronic illnesses. | Track 2 - Community-Centered Innovation |
| Mark Allenby | The University of Queensland | m.allenby@uq.edu.au | Brisbane, Australia | At the University of Queensland, I lead a tissue engineering research group focussing on immune and cardiovascular tissue. This includes engineering lab-grown blood-generating tissue (e.g. marrow) and immune-cardiovascular tissues. Current areas include microfluidic chip fabrication, hydrogels, 3D printing, perfusion cultures, live-cell-tracking, cytokine assays, peripheral and cord blood immune cells, HSPCs, or blood-outgrowth endothelial cells. | At the University of Queensland, my group is focussed on cell therapy manufacturing, blood disease, stem cell transplant, and some forms of cardiovascular disease. We collaborate well with blood transfusion, stem cell transplant, hematology, and cardiovascular clinical, industrial, and academic groups. Our imaging and cytokine assay expertise works very well with mathematical biologists and biophysicists; tracking and modelling imaged cell interactions in different culture environments. | Track 1 - Technology-Driven Innovation |
| Natasha Sheybani | University of Virginia | nds3sa@virginia.edu | Charlottesville, VA | Applications of focused ultrasound technology for non-invasive treatment of neurological disease and cancer | Expertise in Biomedical Imaging techniques, liquid biopsy, cancer biology, patient advocacy | Track 1 - Technology-Driven Innovation |
| Amy Boutwell, MD, MPP | Collaborative Healthcare Strategies | amy@collaborativehealthcarestrategies.com | National; firm based in Lexington, MA | Collaborative Healthcare Strategies catalyzes interdisciplinary, cross-continuum care delivery transformation to improve care in ways that stabilize lives and reduce expensive non-value added emergency room and hospital use. Building on 15 years of clinically credible, locally adaptable, and measurably effective experience leading hundreds of healthcare teams through practice transformation initiatives, our current focus is on developing enabling technology to 10x efficiency of this care pathway | Interdisciplinary, team-based, cross-organization users; clinical care pathway workflow with phases of work triggered by events; each phase is a measurable key process indicator measured against triggered event; AI supported decision support and team communication and collaboration; population and subgroup management, time-based program management; continuous improvement; performance and outcome trending | Track 2 - Community-Centered Innovation |
| Ronke Adetolu | MedConnect | ronkeadetolu@gmail.com | Charlotte, NC | MedsConnect focuses on developing innovative solutions to improve medication adherence through user-friendly, HIPAA-compliant digital platforms. Our research prioritizes behavioral insights, health literacy, and data-driven interventions to support patients in managing their medications effectively and improving health outcomes. | We seek partners who are committed to advancing patient health, including healthcare providers, technology firms, and research institutions. Ideal collaborators offer expertise in digital health, analytics, or community health outreach and share our goal of improving medication adherence and patient outcomes. | Track 2 - Community-Centered Innovation |
| Jeremy Brown | Johns Hopkins University | jdelainebrown@jhu.edu | Baltimore, MD | My research aims to understand the neuroscience of touch perception and how humans use touch sensations for sensorimotor control during dexterous manipulation. Our ultimate aims is to use this knowledge to develop better assistive technologies for individuals with disabilities (e.g., prostheses and rehabilitation devices) and enabling technologies for augmenting human performance (e.g., advanced surgical training interfaces). | We are open to all applications involving human-machine interaction. | Track 1 - Technology-Driven Innovation |
| Jim StClair | MyLigo, Inc | jim.stclair@myligo.io | Austin, TX | Research and development of secure data management and AI/ML to advance digital twins for precision medicine | Academic Medical Centers, Institutions and Centers to provide co-PIs and research data for model development | Track 1 - Technology-Driven Innovation |
| Robin Dubin | AliveAndKickn | robin@aliveandkickn.org | Haworth, NJ | AliveAndKickn’s current research focuses on improving care coordination and outcomes for individuals with Lynch syndrome and other hereditary cancer conditions. Our priorities include developing patient-centered digital tools like the Precision Insight platform, which integrates screening protocols, care navigation, and data centralization. We aim to address gaps in access, education, and care delivery while leveraging community insights to create scalable, real-world solutions. | AliveAndKickn seeks teaming partners who share our commitment to improving cancer care through innovative, patient-centered solutions. Ideal partners bring expertise in digital health, app development, or data integration to help build and scale the Precision Insight platform. We also value collaborators with experience in patient advocacy, hereditary cancer care, or community outreach to ensure the platform addresses real-world needs and fosters meaningful engagement with diverse populations. | Track 2 - Community-Centered Innovation |
| Sepideh Nouri | Vivamed, Inc. | sepideh@vivamedinc.com | Los Angeles, CA | Implantable Medical Devices, Wearables | Projects related to wearables and medical devices | Track 1 - Technology-Driven Innovation |
| Kathleen Agaton | AIRnyc | kagaton@air-nyc.org | New York, NY | Impact of Community Health Workers on building health equity by providing care coordination and addressing social determinants of health for Medicaid-eligible patients with chronic conditions like asthma, COPD, diabetes, hypertension and high-risk birthing persons and children. CHW-led, community-centered participatory research to understand the social and environmental needs and challenges experienced by community residents with chronic conditions. | Design research and testing technological innovations to help community residents connect to needed health and social care, manage and improve chronic conditions, and improve environmental/living conditions. | Track 2 - Community-Centered Innovation |
| James Byrne | University of Iowa | james-byrne@uiowa.edu | Iowa City, IA | Cancer therapies | Immunologies | Track 1 - Technology-Driven Innovation |
| Maria Levis | Impactivo, LLC. | maria.levis@impactivo.com | San Juan, PR | We work with community health centers to address their needs using data and people-centered technology. We are currently doing design-based research with patients and physicians focused on lifestyle medicine, diabetes, and hypertension. | We are interested in a strong technology partner. Our expertise is in working with communities to design solutions. | Track 2 - Community-Centered Innovation |
| Kelley Sullivan | Signature Health Pharmacy | ksullivan@shinc.org | Cleveland, OH | FQCH currently early in research infrastructure building. Our organization has a foundation in behavioral health and substance use disorders and an interest in pursuing research initiatives with a corresponding focus. | Looking for similarly aligned partners who may have research infrastructure further established. Our organization is very committed to furthering research endeavors to enhance patient care. | Track 2 - Community-Centered Innovation |
| Záda Beasley | ZataData | hello@zatadata.world | Hanover, MD | ZataData's research within the EHI ARPA-H underfunded area of women's health focuses on leveraging AI and machine learning to address critical health challenges. Predictive Modeling: We are developing AI models to predict the risk of gynecological cancers like ovarian and cervical cancer. These models utilize a combination of genetic data, lifestyle factors, and medical history for early detection and personalized risk assessment. Maternal and Infant health defining early detection. | An ideal ARPA-H EHI partner for ZataData would possess complementary expertise and resources. Academic Institutions: Leading universities with renowned women's health departments (e.g., Johns Hopkins) can provide access to data, expertise, and research facilities. Healthcare Providers: Large hospital systems can offer real-world data, clinical insights, and patient populations for model validation. Technology Partners - Offering wearable devices, cloud storage, and integration capabilities. | Track 1 - Technology-Driven Innovation |
| Hannah Katz | SciTech Scity | hkatz@lsc.org | Jersey City, NJ | Digital Health, Health IT, Health Equity | We are looking for researchers with strong expertise in digital health or health equity and accelerator and incubation partners, medical professionals, and community organizations. | Track 2 - Community-Centered Innovation |
| Kathryn Whyte | Columbia University Medical Center | kjw2116@cumc.columbia.edu | New York City, NY | Energy balance assessed by whole room calorimetry | layering of additional technology to improve endophenotyping | Track 1 - Technology-Driven Innovation |
| Rebecca Swain-Eng | SEA Healthcare | rswaineng@swainengassociates.com | Frederick, MD | SEA Healthcare advances healthcare quality, equity, and policy through data-driven research. Focus areas include quality improvement, care coordination for aging populations and SBHCs, and addressing social determinants of health. We explore Health IT innovations like FHIR, conduct comparative effectiveness research, tackle workforce challenges, and provide policy recommendations to improve outcomes, reduce costs, and support sustainable, equitable healthcare solutions. | SEA Healthcare seeks partners who excel in health data analytics, research, and innovation aligned with ARPA-H's mission. We value expertise in AI/ML, FHIR interoperability, and scalable tech solutions. Ideal partners bring public health policy insights, a commitment to diversity and equity, and experience addressing health disparities. Collaboration, rapid prototyping, and scaling transformative solutions are key to driving measurable improvements in healthcare delivery and outcomes. | Track 2 - Community-Centered Innovation |
| Mohit Verma | Purdue University | msverma@purdue.edu | West Lafayette, IN | The Verma Lab at Purdue University focuses on enabling lab-quality analyses at the point-of-need. We have achieved this goal using biosensors and ingestible technologies. Examples of such technologies include devices that can rapidly detect DNA and RNA, smart capsules, and spectroscopy-based process analytical tools. Recently, we are also accelerating the process of technology development by leveraging automation and AI-driven experimental design. | We are looking for clinical partners who can help define clinical outcomes and provide appropriate samples for testing newly developed technologies, especially in the lympatic medicine field. | Track 1 - Technology-Driven Innovation |
| Aydin Babakhani | UCLA | aydinbabakhani@g.ucla.edu | Los Angeles, CA | Custom asic design, sensors, medical devices, wearables | Collaborating on projects/proposals related to wearables, medical devices, and custom sensors | Track 1 - Technology-Driven Innovation |
| Meghan Shan | UCSF | jing.shan@ucsf.edu | San Francisco, CA | Building AI tools for healthcare | 2. External model validation | Track 1 - Technology-Driven Innovation |
| Rob Cooley | Nuream | rob@nuream.com | Wilmington, NC | Our thesis holds neurodata is the newest frontier for improved health, wellness and performance outcomes. Insufficient restorative sleep plagues nearly 2/3 of all people. Current models to capture and categorize sleep, such as EEG caps and wearables, are uncomfortable and invasive, or only review ancillary biometric data. Nuream delivers Fabric as a Sensor (FaaS) that allows us to capture, curate and protect neurodata as easily as putting your head on a pillow at night. | We look for strategic partners in the EEG, sleep, advanced materials development neurosensing and neurodata usage environments. We also look for partnerships with leading global organizations that have experience preparing untapped neurodata usage for FDA certification and insurance reimbursement models. | Track 1 - Technology-Driven Innovation |
| Clair Kronk | Icahn School of Medicine at Mount Sinai | Clair.Kronk@mountsinai.org | New York, NY | LGBTQ+ identity representation, comparison, and standards across cohort studies, in electronic health records (EHRs), and in policy; LGBTQ+ health disparities research; integration of research lifespan between research manuscripts, clinical trials, governmental policy, and patents; relationship between spoken language, written language (in EHRs), and patient satisfaction in clinical encounters using natural language processing; assessment of policy impact using pharmaceutical surveillance data | Community-based partnerships; Database engineers; Computer programmers and analysts; Survey researchers; Statisticians; Policy researchers | Track 2 - Community-Centered Innovation |
| Cheryl Lohman | Independent Researcher | Medapptic@gmail.com | Germantown, MD | Research area is remote dementia diagnosis using AI. Kyst Box is a smart storage system (patent pending) with clear pod lids that holds essential elderly care items like dentures and hearing aids. Sensors detect when items are removed or replaced triggering instant notifications to caregivers via our mobile app. The usage data will be used to track progression of dementias remotely via Artificial Intelligence (AI), eg. an increased rate of misplaced items can be a proxy for dementia progression. | Kyst Box Inc. is searching for assisted living testing sites, engineering expertise and manufacturing partners. Testing sites should include 10-40 residents using the Kyst Box for storage. A supervisor will use the phone app dashboard. We are searching for entrepreneurs with a proven track record of translating sensor input data into diagnostic algorithms using AI. We are looking for engineers with experience in AI and gamification techniques for the elderly to increase product usage rates. | Track 1 - Technology-Driven Innovation |
| Kiyana Turner | Health in her HUE | kturner@healthinherhue.com | New York, NY | Health in Her HUE empowers Black womxn and women of color (WOC) to address health issues disproportionately affecting them. Our digital platform connects WOC to culturally responsive healthcare providers, tailored health content, and community support. We have a community of 72K including 1.8K providers across 60 specialties. We offer educational content, live events, and connections like community forums and peer support groups. | We are interesting in teaming with partners who are invested in health equity, closing health gaps for Black women and women of color specifically, and increasing representation of Black women and women of color in clinical trials and consumer studies. | Track 2 - Community-Centered Innovation |
| Benjamin Freedman | Limax Biosciences, Inc. | freedman.br@gmail.com | 240 Longwood Avenue, Boston, MA, MA | Development of tough and stretchable hydrogel-based bioadhesives for diverse wet surfaces. Materials seal leaks, heal tissues, and delivery therapeutics locally. | Integration of novel sensors and therapeutics into material system. | Track 1 - Technology-Driven Innovation |
| Ziteng Wang | Northern Illinois University | zwang3@niu.edu | DeKalb, IL | AI/ML, mathematical optimization, analytics, supply chain | domain experts in health, experts with expertise in data analysis from specialized areas | Track 1 - Technology-Driven Innovation |
| Taylor Hooker | VHA | Hooker.Taylor@gmail.com | San Francisco, CA | Tech-enabled social connection to address social isolation and loneliness via recreational therapy and focused community building. | Product developers, social impact strategists, organizations who can “house” this solution | Track 2 - Community-Centered Innovation |
| Bevin Wathen | Wathen Innovations | bwgdeveloper@icloud.com | Louisville, KY | Digital transformation for individuals, community, communities, and institutions | It depends on further clarification of needs and priorities | Track 1 - Technology-Driven Innovation |
| Siwei Zhao | University of Nebraska Medical Center | siwei.zhao@unmc.edu | Omaha, NE | We are developing novel electrotherapies for neuromuscular regeneration, pain management, wound healing, and non-invasive drug delivery. We developed a hydrogel ionic circuit (HIC) system that can apply high-strength electric current to biological tissues without causing tissue damage. We showed that the high-strength electric current applied by our system can significantly enhance the iontophoretic drug delivery efficiency and chronic wound biofilm treatment efficacy. | We are looking for collaborators to expand the clinical applications of our HIC technology. | Track 1 - Technology-Driven Innovation |
| Kinneret Rand | AkriVita | kinneret@akrivita.com | Rockville, MD | AkriVita develops 3D-printed microcapillary needles for research, biomedical, and clinical applications, including genetic engineering, transgenics, disease modeling and treatment (e.g., Alzheimer’s and stroke), and fertility treatments. Utilizing two-photon direct laser writing (DLW), we address calibration variability while enhancing precision, reproducibility, and scalability, advancing genetic research, biotechnology, and clinical applications with innovative, reliable solutions. | 3. Additive manufacturing and microfluidic devices specialists, testing and validation partners, commercialization and scaling partners, industry leaders in biotechnology and medical devices, Partners who share AkriVita's commitment to innovation, reliability, and addressing critical challenges in biomedical and clinical research. | Track 1 - Technology-Driven Innovation |
| Stephanie Wankowicz | Vanderbilt University | stephanie@wankowiczlab.com | Nashville, TN, USA, TN | The Wankowicz lab focuses on deciphering the mechanism underlying binding specificity and catalysis through a thermodynamic and structural lens. While specific macromolecular interactions are fundamental to life, our structural understanding of these interactions remains incomplete, limiting our ability to fully grasp the mechanisms driving human biology and disease. We believe that a significant contributor to this gap is the insufficient attention of how entropy influences enzyme function. | We build computational algorithms to enable us to better connect structural features, including structural ensembles, to biophysical measurements of entropy. We are interested in teaming with medicinal chemists or protein design teams to integrate entropy into these efforts. We are also interested in engaging with the scientific software community to learn how to best extract ensemble information from experimental structural biology data, which is critical to connecting structure to entropy. | Track 1 - Technology-Driven Innovation |
| Yuanxiong Guo | University of Texas at San Antonio | guoyuanxiong@gmail.com | San Antonio, TX | We are a team of CS researchers with expertise in machine learning, deep learning, foundation models, and large language models | We are seeking domain experts in allogenic human leukocyte antigen matching, preferably from medical schools. | Track 1 - Technology-Driven Innovation |
| Claire Saxton | Cancer Support Community | csaxton@cancersupportcommunity.org | Identifying needs & insights/perceptions, as well as evaluating psychosocial & HRSN interventions for cancer previvors, patients, survivors, and caregiver; Cancer patient & caregiver PROs; Distress screening; identifying patient & caregiver navigation needs (for CHWs, financial/psychosocial navigators, & clinical navigators) | Technology partners to enhance the reach of psychosocial & HRSN interventions for cancer previvors, patients, survivors, and caregivers. | . | |
| Margie Sutton | UT MD Anderson Cancer Center | mnsutton@mdanderson.org | Houston, TX | Our research group leverages molecular imaging and systems biology approaches to drive therapeutic discovery for applications across inflammation and cancer. Using an iterative approach with a multidisciplinary team we have successfully developed radiopharmaceuticals, therapeutic antibodies and molecular imaging probes for clinical translation, and aim to leverage these interventions and imaging applications to understand lymphatic biology and transform lymphatic medicine. | We seek teaming partners with expertise in models of lymphatic disease and dysfunction, or with an interest in molecular imaging capabilities to enhance their program, specifically at the immune/lymphatics interface. | Track 1 - Technology-Driven Innovation |
| Anna Welland | Charles River Community Health | awelland@charlesriverhealth.org | Boston, MA | We are exploring ways in which we can partner with academic and industry partners doing research to bring equity and access to all. Charles River Community Health (CRCH) is a Federally Qualified Health Center (FQHC), serving the most vulnerable and underserved populations. Of our 13,513 patients in FY24, 91.5% identify as BIPOC, 75.8% patients need services in a language other than English, 80.37% are at or below the federal poverty level and over 30% are uninsured or underinsured. | As an FQHC we are limited in our resources in capital, personnel capacity, and wages offered to staff and providers, we are not able to access the latest trainings and technology. Also, due to rising needs of our existing patients further compounded by other social determinants of health (limited food access, environmental factors, and other) plus an increasing volume of new patients, we lack the time and resources to seek opportunities for learning and partnerships to elevate equitable access. | Track 2 - Community-Centered Innovation |
| Greg Miller | Health Tech Alley | gmiller@healthtechalley.org | Columbia, MD | Use of emerging tech and data science within the Care Economy to assist in serving vulnerable populations. In particular, we are partnered with a primary care clinic specializing in serving physically disabled patients and a foundation providing family support for the same population. We are exploring use of AI-enabled services, through community-based primary care, to improve the quality of patient life and assist nurses and care givers in being most productive. | Research-based organizations with qualification in treatments for complex health conditions particularly physically disabled. Technology-based providers (AI-ML, IoT, distributed ledger, open source solutions, etc.) focused on the intersection of population health and technology. | Track 2 - Community-Centered Innovation |
| Shyam Saladi | Neelyx Labs | Shyam.saladi@neelyx.com | Chicago, IL | At Neelyx, we believe the future of healthcare is at home; and that future is only possible if people can self-collect their own samples in the comfort of their own home. We’re making this a reality across the clinical laboratory menu not just by building and distributing home kits but also by pursuing regulatory clearances, billing codes, and partnerships with all parts of the healthcare ecosystem. | We are looking for community-based and traditional healthcare organizations who provide healthcare services to a patient population, in whatever form that might be. | Track 1 - Technology-Driven Innovation |
| Patricia Khashayar | International Institute for biosensing, University of Minnesota | pkhashay@umn.edu | minneapolis, MN | (bio)sensing | multi-modal (bio)sensors | Track 1 - Technology-Driven Innovation |
| Norman Coulter Jr. | Unc Guidance Group | Normanleadsself@gmail.com | Pasadena, CA | My organization's current research focus explores the cultivation of self-leadership and emotional regulation among Black and Latino adolescent males (BLAM) through curated generative artificial intelligence (CGAI) companions. CGAI refers to next generation artificial intelligence tools designed specifically to address the unique emotional and social needs of marginalized communities, particularly BLAM. At the center of this research is a customized GPT known as "Unc AI, Your 3 A.M." | We are looking for experts in AI and Machine Learning, experience in youth development, mental health professionals, trust community organizations, educational institutions, tech developers, and funding/grant agencies. | Track 2 - Community-Centered Innovation |
| Katharina Maisel | University of Maryland | maiselka@umd.edu | College Park, MD | Ourresearch integrates nanotechnology, materials science, and tissue engineering with physiology, medicine, and immunology to probe lymphatics and extracellular barriers via novel ex vivo and in vitro models and nanoparticles. Our progress lies in understanding how nanoparticle material properties affect their transport across biological barriers including lymphatic vessels and lymph node interstitial tissues, and designing nanotechnology to study biological barriers and design therapeutics. | -expertise in mucosal diseases/infection -expertise in lymphatic biology -expertise in imaging | Track 1 - Technology-Driven Innovation |
| Omar Costilla Reyes | Equ Healthcare | omar@equ.care | Boston, MA | Our organization focuses on advancing health equity through culturally tailored, transparent AI solutions for the Hispanic/Latino community. Current research includes neurosymbolic AI for personalized medicine, real-time data integration for metabolic and mental health, and community-centered innovations like AI-powered diet/activity coaching, asthma management, and environmental monitoring tools. We aim to empower individuals and communities with scalable, equitable healthcare technologies. | We seek teaming partners with expertise in culturally tailored healthcare delivery, AI/ML development, and community engagement. Ideal collaborators include academic researchers, healthcare providers, and community-based organizations with capabilities in data integration, wearable technology, or behavioral science. We value shared commitment to advancing health equity to enhance personalized, scalable healthcare solutions. | Track 2 - Community-Centered Innovation |
| Miguel Jimenez | Boston University | jmiguelj@bu.edu | Boston, MA | Our group develops microbial devices which combine genetically engineered cells with electronic and mechanical components to make chemical sensors and actuators. Our group develops material, genetic and fabrication approaches to enable integration of these living components into products that can be used for human health as diagnostics and therapies. | We are looking for disease experts with a need to sense or dose specific molecules not easily measured or made by traditional processes. | Track 1 - Technology-Driven Innovation |
| Anthony Flammia | Angels for Change | anthonyflammia@angelsforchange.org | Tampa, FL | Angels for Change focuses on researching the root causes and impacts of drug shortages to develop sustainable solutions for a resilient pharmaceutical supply chain. Key areas include analyzing systemic vulnerabilities, enhancing supply chain transparency and reliability, and advocating for policy reforms to ensure consistent medication availability. | Angels for Change seeks teaming partners who share a commitment to ending life-threatening drug shortages and advancing healthcare resilience. Ideal partners include stakeholders from healthcare, pharmaceutical manufacturing, policy, and advocacy sectors who can contribute expertise, resources, and innovation to collaborative initiatives. | Track 2 - Community-Centered Innovation |
| Claire Saxton | Cancer Support Community | csaxton@cancersupportcommunity.org | CSC has 196 local Cancer Support Community and Gilda's Club locations in 52 markets in 30 states & 2 Canadian provinces where we do outreach to historically underserved cancer patients, previvors, survivors, and caregivers. | CSC's mission os that Everyone impacted by cancer receives the support they want and need throughout their experience. We are interested in talking to partners who help support people effected by cancer. | . | |
| Fiona Kolbinger | Purdue University | fkolbing@purdue.edu | West Lafayette, IN, IN | My lab's focus is AI-based decision support in medicine, primarily surgery and interventional medicine. Our primary focus areas are (1) prediction of disease trajectories and complications from multimodal clinical routine data (i.e., imaging, tabular data, laboratory parameters) and (2) intraoperative surgical decision support based on real-time analysis of surgical video data. | We are looking for partners with complementary and additional expertise both in the healthcare sector to form multicenter consortia and in the electrical and computer engineering domain to explore technical solutions for privacy-preserving collaborative AI and for explainability evaluation. | Track 1 - Technology-Driven Innovation |
| Sanjay Purushotham | University of Maryland Baltimore County | psanjay@umbc.edu | Baltimore, MD | Our expertise lies in AI, Machine Learning, and Federated Learning, particularly in the healthcare domain. Our current research focuses on areas such as Multimodal Generative AI, Medical Image and Video Visual Question Answering (VQA), Explainable AI, Synthetic Data Generation, Privacy-preserving methods, Machine Learning reproducibility and benchmarking. | Clinicians, health science experts, medical organizations, healthcare professionals, Medical device partners, EHR data vendors | Track 1 - Technology-Driven Innovation |
| Todd Quartiere | Foundation for AI & Health | todd.quartiere@faih.org | Durham, NC | Our mission is to inspire the adoption of responsible AI for health by sparking imagination, advancing literacy, and fostering community. We’re an industry-led organization that helps others learn digital literacy and understand how to balance principles of responsibility with opportunity. Our programming includes educational events, technical workshops, and an open-source library for psychology-led best practices when dangerous behavioral health is detected by an AI. | We seek partners who share our commitment to advancing responsible AI for health through imagination, education, and community-building. Ideal collaborators bring expertise in digital health, behavioral science, or technical development to enhance AI literacy and safety. We value diversity and the ability to co-create solutions that balance responsible principles with cutting-edge opportunities, supporting initiatives like our open-source library for AI-driven behavioral health best practices. | Track 2 - Community-Centered Innovation |
| Susan Houser | MRIGlobal | shouser@mriglobal.org | Kansas City, MO | We offer a diverse portfolio of services ranging from diagnostics, surveillance, bioinformatics, support of lab ops, pharmaceutical services and a repository with a foreign trade zone. | We are always interested in partnering with companies that offer unique services and niche offerings. As a CRO, we are flexible and offer a diverse portfolio of capabilities that can pair well with potential partners. | Track 1 - Technology-Driven Innovation |
| Tien fofvo5-Xofzez-zokkyg | CareCost AI | Tyhtienyu@gmail.com | Boston, MA | Our AI agent helps you navigate the American healthcare so you dont have to. Find the right care, avoid denials, and get answers to Your Medical Bill Questions, using Recent Medical Bills, Hospital Pricing, Your Insurance Policy and Doctor Ratings | clinicians looking to grow their business, payers or employers looking to reduce medical costs reimbursement, pharma or clinical trial operators looking to recruit partici[ants, community looking for transparency in healthcare, Americans on high deductible insurance plans looking to save on medical bills | Track 1 - Technology-Driven Innovation |
| Tyona Pike | F&I Foresight Initiatives | Pikesforesightinitiatives@gmail.com | Cookeville, TN | Our focus includes supporting patients, caregivers, families, and medical teams by addressing unmet needs, enhancing awareness, and fostering partnerships to advance diagnosis, treatment, and care. We aim to work with organizations to reduce diagnostic delays, improve patient outcomes, and develop patient-centric approaches that prioritize the unique challenges posed by rare diseases | seeking a partner to handle the technical and research aspects of our efforts in the rare disease space. While we focus on growing and maintaining support for patients, caregivers, friends and family, medical teams, and those aiding individuals along the diagnostic odyssey, we aim to collaborate with an organization that can enhance our research capabilities and drive innovative solutions. Together, we can create a comprehensive support system that addresses the unique challenges. | Track 2 - Community-Centered Innovation |
| Kelsey Pratt | Phreesia, Inc. | kelsey.pratt@phreesia.com | Wilmington, DE | Phreesia is a leading digital technology provider supporting healthcare intake, patient-reported data collection, surveys, patient education, and patient activation. Phreesia leverages its network of 4,000+ US healthcare practices, over 150 million patient check-ins each year, and integration with 80% of the US EMRs market to better understand patients’ healthcare gaps and needs, deliver education and drive behavior change, and support individuals’ knowledge and ability to manage their health. | Organizations with which to partner to collect data to inform gaps, test and try new solutions in real-world settings, support disease awareness and prevention, and drive better patient activation and chronic disease management. | Track 1 - Technology-Driven Innovation |
| Mike Galvin | LivAi | Mike@livai.ai | San Francisco, CA | Handzin is a private platform built to support communities. Handzin does not mine or profit from client data, it is a trusted space for collaboration using video, chat, teaming and harnessing AI. Handzin is building towards AI Agents supporting both individual and group healthcare advocacy. From simply forming community right to driving data driven projects to find cures. | Private patient communities looking to transform their healthcare. Building private communities to manage research, patient navigation, community and government advocacy. Groups that want to collaborate and use their own data to drive change. Groups wanting to come off facebook and social media to work in private | Track 1 - Technology-Driven Innovation |
| Guan Wang | AFFOA | gwang@affoa.org | Cambridge, MA | National Manufacturing Institute with a focus on advanced textile technologies. Research area focus includes advanced sensing and actuation technology integrated into textile form factors. 3D and circular knitting, weaving and embroidery available at our facility along with electronics and soft system integration and product design. We also have 150 member network from the domestic supply chain ready to bring a domestic supply chain to those working to accelerate a product's time to market. | AFFOA seeks teaming partners with: 1. unique biosensors seeking to collaborate to incorporate those sensors into advanced textile materials. 2. experience in medical device commercilization and FDA regulation | Track 1 - Technology-Driven Innovation |
| Bob Snyder | Proteios Technology, Inc. | bob@proteios.com | Seattle, WA | Focus on the isolation of advanced therapeutics, including: immune cells, proteins, antibodies. | Looking to team with a partner who is developing an advanced therapeutic where we can provide the isolation technology. For example, the development of cell isolation methods based on new surface antigens for CAR-T cell therapies. | Track 1 - Technology-Driven Innovation |
| Juliane Sempionatto | Rice University | jsemp@rice.edu | Houston, TX | Wearable biosensors for health monitoring. Use of non invasive biofluids such as sweat, saliva, tears and Interstitial fluid. Implantable sensors, and epidermal sensors for continuous monitoring of target analyte. | Expert in new biosensors, flexible materials, implantable technology, electronics, machine learning | Track 1 - Technology-Driven Innovation |
| Patrick Mendez, PhD | University of Maryland | Pmendez1@umd.edu | College Park, MD | Open | Open | Track 2 - Community-Centered Innovation |
| MD Ahasan Habib | Rochester Institute of Technology | mahmet@rit.edu | Rochester, NY | Our research group focuses on advancing biomedical research through innovation technologies like patient-specific 3D bioprinted models and dynamic bioreactors. Current projects address critical healthcare challenges, such as Polycystic Kidney Disease (PKD), by replicating patient-specific microenvironments, improving cell viability, and developing AI-driven monitoring systems. Additionally, we have developed a smart 3D bioprinter capable of providing tissue-specific recipes. | Cell biology, AI-expert, control and sensor experts. | Track 1 - Technology-Driven Innovation |
| Eric Claude | MPR Associates | eclaude@mpr.com | Alexandria, VA | MPR's Health and Life Science Team provides services for design, development, engineering, and testing in the medical device, diagnostics, and pharmaceutical industries. We help innovators accelerate time to market with novel medical technologies, reduce risk for patients, improve operational efficiencies, and ensure regulatory compliance. With our team of 250 engineers, designers, and scientists, MPR brings hands-on expertise to support translation of innovations from lab to production. | MPR seeks to partner with Performers or other Spokes who may wish to leverage our capabilities to reduce risk and accelerate commercialization, including through - Technology evaluation, solution definition, and concept design, - Rapid development of devices for bench-top feasibility as well as preclinical and human clinical studies, - Product commercialization planning and road-mapping, - Design and development for rapid scale-up and deployment, - Development of FDA-required documentation | Track 1 - Technology-Driven Innovation, Track 2 - Community-Centered Innovation |
| Patrick Slade | Harvard University | slade@seas.harvard.edu | Cambridge, MA | Our lab is focused on advancing wearable sensing and assistive technologies for understanding and overcoming mobility challenges. This includes remote monitoring of physical activity, digital twins of the musculoskeletal system, and personalized digital medicine tools. In terms of assistive robotics we're interested in personalizing assistance for many different kinds of devices like exoskeletons, orthoses, prostheses, and biofeedback systems. | We're looking for potential partners that innovate on new sensing modalities to inform our wearable sensing or assistive technology as well as patient population experts with expertise in specific mobility challenges to work together in developing new solutions. | Track 1 - Technology-Driven Innovation, Track 2 - Community-Centered Innovation |
| Elizabeth Cohn | CUNY | elizabeth.cohn@hunter.cuny.edu | New York, NY | The use of large data sets by community to accelerate community health. | Community-based biostatisticians and AI experts. | Track 2 - Community-Centered Innovation |
| Yue Luo | San José State University | yue.luo@sjsu.edu | San Jose, CA | Human machine interaction, human factors, data analytics | social scientist | Track 1 - Technology-Driven Innovation |
| Xuejun Parsons | San Diego Regenerative Medicine Institute | jparsons001@san.rr.com | San Diego, CA | San Diego Regenerative Medicine Institute was founded to facilitate transition of human stem cell research towards stem cell therapy to provide the next generation of cell-based therapeutic solutions for unmet medical challenges in world-wide major health problems, committed to the leading position in pluripotent human embryonic stem cell (hESC) research and cell-based regenerative medicine by developing groundbreaking hESC technology platforms and innovative regenerative medicine approaches. | open to partnership, investment, GMP manufacturing facility partner, and licensing to a large pharma company | Track 1 - Technology-Driven Innovation |
| Alex Train | La Colaborativa | alext@la-colaborativa.org | Chelsea, MA (Boston, MA), MA | A preeminent Latinx-led nonprofit organization situated north of Boston, La Colaborativa deploys innovative direct services, advances equitable public policy, and cultivates leadership development to realize systems change. In partnership with Mass General Brigham, we address social determinants of health, enhance access to preventative care services, and design unique modes of healthcare delivery for BIPOC communities in an environment laden with skepticism and distrust of institutions. | strengthening internal research infrastructure, including data management systems, research staff, and partnerships with academic institutions, is a paramount priority of La Colaborativa. Prospective partners should be mission-aligned, diverse, and exhibit an openness to experimental approaches to community-based care. | Track 2 - Community-Centered Innovation |
| Zhen Xiao | Truvante LLC | zhen.xiao@truvante.com | Lorton, VA | Develop Digital Health Technologies for Children's Mental and Developmental Health | Academic, Non-profit, and Industry | Track 2 - Community-Centered Innovation |
| Pranam Chatterjee | Duke University | pranam.chatterjee@duke.edu | Durham, NC | My lab at Duke focuses on the development of new generative language models for biomolecular design, with a particular focus on peptide and protein therapeutics. This allows us to generate de novo molecules with optimal therapeutic properties. Finally, as my lab has full capability in theoretical algorithm development all the way through in vitro testing and in vivo delivery, we aim to rapidly translate the outputs of our algorithms to the clinic. | We are able to tackle numerous diseases rapidly and simultaneously. For example, we are currently developing peptide therapeutics (think GLP-1 agonist-like molecules) for numerous neurodegenerative diseases, pediatric cancers, substance use disorders, and ovarian diseases. We would like to partner with institutes and medical systems with strong pre-clinical and clinical development capabilities who can rapidly translate our work. | Track 1 - Technology-Driven Innovation |